• About
  • Advertise
  • Privacy & Policy
  • Contact
Marijuana with Hemp
  • Home
  • Politics
  • Business
  • Lifestyle
  • Medical
  • Shop
No Result
View All Result
  • Home
  • Politics
  • Business
  • Lifestyle
  • Medical
  • Shop
No Result
View All Result
Marijuana with Hemp
No Result
View All Result
Home Featured

Some reactions to a potential marijuana rescheduling

Graham Cooper by Graham Cooper
December 17, 2025
in Featured, Politics
0
Some reactions to a potential marijuana rescheduling
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter
404

The rumors keep coming in, with the newest saying that a decision will be made tomorrow, December 18th, about changing the scheduling of marijuana from Schedule I to Schedule III.

It’s almost seeming certain at this point, so the reactions are flooding in.

Some of them are very unhappy, including some voices from the GOP establishment.

Representative Mike Lawler, a Republican from New York, told The Hill that it would be a bad idea.

“The fact is, marijuana is a gateway drug. Most of the people [who] end up using harder substances start out on marijuana… The THC content in marijuana is significantly higher today than it was 30, 40 years ago. And so when you look at the challenges that we’re facing as a country with substance use disorder, I don’t think rescheduling marijuana is wise. I’m opposed to that.”

Then there are the Democrats who are a little salty that Trump is taking their issue. For instance, Senator Ron Wyden from Oregon has tweeted that this isn’t legalization, just something to make Trump look good.

“Trump will try to gaslight everyone into believing he just made pot legal. Wrong. He has not decriminalized cannabis or expunged the records of black and Latino Americans stuck in prison for minor drug offenses. This is just an attempt to boost his pathetic approval ratings.”

Trump will try to gaslight everyone into believing he just made pot legal. Wrong. He has not decriminalized cannabis or expunged the records of black and Latino Americans stuck in prison for minor drug offenses. This is just an attempt to boost his pathetic approval ratings. https://t.co/JvCuhLycxA

— Ron Wyden (@RonWyden) December 12, 2025

While the motivation may very well be true, this will certainly be a huge boon for marijuana businesses who are struggling in a legal limbo.

As a whole, pot smokers will certainly be happy about these proposed changes.

A new poll has come out that shows marijuana consumers are not happy with Trump’s inaction to date, with only 6% approving.

 

 

 

 

 

 

 

 

However, if he were to change marijuana to Schedule III, that 51% of them would change their mind about his actions. This is sort of obvious, considering he hasn’t done anything at all towards reform since he’s been in office, but still shows much public opinion could sway after these actions.

Perhaps those “pathetic approval ratings” may get swayed after all.

Visits: 423
Previous Post

Weed Rescheduling is in the air

Next Post

Two New Cannabis Compounds Found as Promising Candidates for Treating Ovarian Cancer

Graham Cooper

Graham Cooper

Related Posts

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings
Business

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

by Keegan MacDonald
September 8, 2026
How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults
Cannabis Research

How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

by Keegan MacDonald
September 8, 2026
Trump delays Hemp THC Ban
Featured

Trump delays Hemp THC Ban

by Graham Cooper
September 7, 2026
Ron DeSantis misappropriated funds to anti-cannabis PAC
Featured

Ron DeSantis misappropriated funds to anti-cannabis PAC

by Graham Cooper
September 7, 2026
Deadly Explosion at Oklahoma Marijuana Facility Raises Industry Safety Concerns
Business

Deadly Explosion at Oklahoma Marijuana Facility Raises Industry Safety Concerns

by Keegan MacDonald
September 6, 2026
Next Post
Two New Cannabis Compounds Found as Promising Candidates for Treating Ovarian Cancer

Two New Cannabis Compounds Found as Promising Candidates for Treating Ovarian Cancer

ADVERTISEMENT
  • Former NBA Player Smoked Cannabis Before Interviewing Kamala Harris

    Former NBA Player Smoked Cannabis Before Interviewing Kamala Harris

    0 shares
    Share 0 Tweet 0
  • Ted Cruz jokes about smoking weed with Elon despite opposition to legalization

    0 shares
    Share 0 Tweet 0
  • More Pregnant Women Are Smoking Weed

    0 shares
    Share 0 Tweet 0
  • Where is marijuana on the ballot in November?

    0 shares
    Share 0 Tweet 0
  • Marijuana is legal… Now what?

    0 shares
    Share 0 Tweet 0
  • Trending
  • Comments
  • Latest
How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

September 8, 2026
Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

September 8, 2026
How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

0
Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

0
Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

September 8, 2026
How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

September 8, 2026
ADVERTISEMENT
Marijuana with Hemp

Browse by Category

  • Age Restrictions
  • Air Travel
  • American Culture
  • Animal Health
  • Anxiety Relief
  • Ballot Initiative
  • Bioplastics
  • Bipartisan Bill
  • Bipartisan Politics
  • Business
  • Canada
  • Cancer
  • Cancer Care
  • Cancer Treatment
  • Cannabinoid Receptors
  • Cannabinoids
  • cannabis
  • Cannabis Brands
  • Cannabis Business
  • Cannabis Culture
  • Cannabis Extraction
  • Cannabis Finance
  • Cannabis Health Risks
  • Cannabis Industry
  • Cannabis Legalization
  • Cannabis Legislation
  • Cannabis Market
  • Cannabis Mergers
  • Cannabis Policy
  • Cannabis Reform
  • Cannabis Regulation
  • Cannabis Research
  • Cannabis Tax
  • Cannabis Tourism
  • Cannabis Travel
  • Cannabis Trends
  • Cannabis Use Disorder
  • Cardiovascular Effects
  • CB1 Receptor
  • CB2 Receptor
  • CBD
  • Cigarette Smoking
  • Colorado
  • Congress
  • Congressional Amendment
  • Consumer Health
  • Controlled Substances Act
  • Criminal Justice
  • Criminal Justice Reform
  • Culture
  • DEA
  • Deceptive Marketing
  • Democrats
  • Dispensary Closures
  • DMV Region
  • Donald Trump
  • Drug Policy
  • Employment Law
  • Endocannabinoid System
  • Entourage Effect
  • Environment
  • Farm Bill
  • FBI Data
  • FDA
  • Featured
  • Federal Cannabis Law
  • Federal Cannabis Policy
  • Federal Law
  • Federal Lawsuit
  • Federal Regulation
  • Georgia
  • Glioblastoma
  • Green Thumb Industries
  • Gun Rights
  • Health Research
  • Health Studies
  • Heart Health
  • Hemp
  • Hemp Politics
  • Hemp Regulation
  • Hemp-Derived THC
  • Illegal Market
  • Industry Risks
  • Insomnia
  • Investors
  • Jeff Sessions
  • Job Loss
  • John Fetterman
  • John Hickenlooper
  • Kratom
  • Law Enforcement
  • Lawmakers
  • Legal Cannabis Industry
  • Legal Compliance
  • Legal Precedent
  • Legalization
  • Legislation
  • Lifestyle
  • Lower Back Pain
  • Marijuana
  • Marijuana Arrests
  • Marijuana Clemency
  • Marijuana Descheduling
  • Marijuana Extracts
  • Marijuana IPOs
  • Marijuana Legalization
  • Marijuana Policy
  • Marijuana Reform
  • Marijuana Regulation
  • Marijuana Safety
  • Marijuana Use
  • Marijuana Users
  • Marijuana Withdrawal
  • Maryland
  • Massachusetts
  • Medical
  • Medical Cannabis
  • Medical Claims
  • Medical Marijuana
  • Medical Research
  • Mental Health
  • Michael Bennet
  • Michigan Cannabis
  • MJBizDaily
  • Mood Disorders
  • MSOs
  • Nasdaq
  • New Jersey
  • Nightmares
  • North Carolina
  • NYSE
  • Oklahoma
  • Older Adults
  • Opioid Reduction
  • Packaging
  • Pain Management
  • Patient Care
  • Pets
  • Police Search
  • Policy
  • Politics
  • Potent Cannabis
  • Pre-rolls
  • Product Safety
  • Psychedelics
  • PTSD
  • Public Education
  • Public Health
  • Public Listings
  • Public Safety
  • Rand Paul
  • Recreational Marijuana
  • Regulation
  • Regulatory Challenges
  • Regulatory Compliance
  • Retail Strategy
  • Second Amendment
  • Sharon Stone
  • Sleep Disorders
  • Small Business
  • SNDL
  • Social Equity
  • State Budget
  • State Cannabis Officials
  • State Legalization
  • State Legislation
  • Substance Use
  • Supreme Court
  • Sustainability
  • Symptom Management
  • Terpenes
  • Testosterone
  • THC
  • THC Potency
  • THC Products
  • Trump Administration
  • TSA
  • U.S. Senate
  • Uncategorized
  • Underage Cannabis Use
  • Uplisting
  • US Cannabis
  • US Cannabis Market
  • US Politics
  • US Study
  • USPS
  • Veterans
  • Veterans Affairs
  • Virginia
  • World Cup 2024
  • Young Men

Recent News

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

Marijuana IPOs Set to Reshape the Market as NYSE and Nasdaq Eye Cannabis Listings

September 8, 2026
How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

How Medical Cannabis is Impacting Pain, Sleep, and Mood in Older Adults

September 8, 2026

© 2026 Marijuana with Hemp

No Result
View All Result
  • Home
  • Politics
  • Business
  • Lifestyle
  • Medical
  • Shop

© 2026 Marijuana with Hemp

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?